Skip to content

Jorge Ledesma, PhD, MPH

jorge.r.ledesma@kp.org

Ledesma, Jorge

Jorge Ledesma, PhD, MPH, is a postdoctoral delivery science research fellow at the Kaiser Permanente Northern California (KPNC) Division of Research. His research interests include designing, implementing, and evaluating novel interventions for improving the cascade of care for a wide range of infectious diseases. His current work is focused on investigating gaps in tuberculosis infection screening and treatment targets across high-risk populations.

Prior to his arrival at KPNC, Jorge completed his PhD in Epidemiology at the Brown University School of Public Health where he received rigorous training in causal inference while producing a research program aiming to improve health system resilience. He also earned his Master of Public Health from the University of Washington (UW). At UW, he was the primary modeler for global tuberculosis burden estimation in the Global Burden of Disease (GBD) study within the Institute for Health Metrics and Evaluation.

Current Positions

  • Delivery Science Research Fellow

Section Affiliations

Primary Research Interests

  • Causal inference
  • Delivery and implementation science
  • Infectious disease epidemiology
  • Social determinants of health
  • Pharmacoepidemiology

Publications

Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.

Authors: GBD 2021 Tuberculosis Collaborators

Lancet Infect Dis. 2024 Jul;24(7):698-725. doi: 10.1016/S1473-3099(24)00007-0. Epub 2024 Mar 19.

PubMed abstract

Community Mitigation Strategies, Mobility, and COVID-19 Incidence Across Three Waves in the United States in 2020.

Authors: Ledesma, Jorge R;Zou, Lin;Chrysanthopoulou, Stavroula A;Giovenco, Danielle;Khanna, Aditya S;Lurie, Mark N

Epidemiology. 2023 Jan 01;34(1):131-139. doi: 10.1097/EDE.0000000000001553. Epub 2022 Nov 30.

PubMed abstract

Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019.

Authors: GBD 2019 Tuberculosis Collaborators

Lancet Infect Dis. 2022 Feb;22(2):222-241. doi: 10.1016/S1473-3099(21)00449-7. Epub 2021 Sep 23.

PubMed abstract

Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis.

Authors: Ledesma, Jorge R;Ma, Jianing;Zheng, Peng;Ross, Jennifer M;Vos, Theo;Kyu, Hmwe H

BMC Infect Dis. 2021 May 22;21(1):467. doi: 10.1186/s12879-021-06141-4..

PubMed abstract

Back To Top